1Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Dorval, Quebec, Canada.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Cloning leukotriene receptors remains a challenge, hindering the development of novel therapies for inflammatory conditions. Successful cloning will enable identification of receptor subtypes and potential therapeutic targets.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: